Bri-Chem Balance Sheet Health

Financial Health criteria checks 4/6

Bri-Chem has a total shareholder equity of CA$22.5M and total debt of CA$30.2M, which brings its debt-to-equity ratio to 134%. Its total assets and total liabilities are CA$68.4M and CA$45.8M respectively.

Key information

134.0%

Debt to equity ratio

CA$30.20m

Debt

Interest coverage ratio1.1x
Cashn/a
EquityCA$22.54m
Total liabilitiesCA$45.83m
Total assetsCA$68.37m

Recent financial health updates

No updates

Recent updates

Bri-Chem Corp.'s (TSE:BRY) Shares Leap 28% Yet They're Still Not Telling The Full Story

Feb 07
Bri-Chem Corp.'s (TSE:BRY) Shares Leap 28% Yet They're Still Not Telling The Full Story

Bri-Chem Corp.'s (TSE:BRY) Shares Not Telling The Full Story

Aug 29
Bri-Chem Corp.'s (TSE:BRY) Shares Not Telling The Full Story

Returns On Capital Are A Standout For Bri-Chem (TSE:BRY)

Mar 31
Returns On Capital Are A Standout For Bri-Chem (TSE:BRY)

Bri-Chem (TSE:BRY) Knows How To Allocate Capital Effectively

Jun 11
Bri-Chem (TSE:BRY) Knows How To Allocate Capital Effectively

We Think That There Are Issues Underlying Bri-Chem's (TSE:BRY) Earnings

Apr 06
We Think That There Are Issues Underlying Bri-Chem's (TSE:BRY) Earnings

Bri-Chem's (TSE:BRY) Returns On Capital Are Heading Higher

Dec 31
Bri-Chem's (TSE:BRY) Returns On Capital Are Heading Higher

Financial Position Analysis

Short Term Liabilities: BRY's short term assets (CA$54.2M) exceed its short term liabilities (CA$38.3M).

Long Term Liabilities: BRY's short term assets (CA$54.2M) exceed its long term liabilities (CA$7.5M).


Debt to Equity History and Analysis

Debt Level: BRY's net debt to equity ratio (134%) is considered high.

Reducing Debt: BRY's debt to equity ratio has reduced from 196.5% to 134% over the past 5 years.

Debt Coverage: BRY's debt is well covered by operating cash flow (42%).

Interest Coverage: BRY's interest payments on its debt are not well covered by EBIT (1.1x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.